Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis

Conditions:   Dermatomyositis;   PolymyositisInterventions:   Drug: tocilizumab;   Drug: placeboSponsors:   University of Pittsburgh;   Genentech, Inc.Recruiting - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials